These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 10788334

  • 1. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
    Górski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzańska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubiński J.
    Am J Hum Genet; 2000 Jun; 66(6):1963-8. PubMed ID: 10788334
    [Abstract] [Full Text] [Related]

  • 2. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T.
    Ann Acad Med Stetin; 2003 Jun; 49():27-43. PubMed ID: 15552838
    [Abstract] [Full Text] [Related]

  • 3. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M, Wysocka B, Brozek I, Jassem J, Limon J, Olah E.
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [Abstract] [Full Text] [Related]

  • 4. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
    Martin AM, Blackwood MA, Antin-Ozerkis D, Shih HA, Calzone K, Colligon TA, Seal S, Collins N, Stratton MR, Weber BL, Nathanson KL.
    J Clin Oncol; 2001 Apr 15; 19(8):2247-53. PubMed ID: 11304778
    [Abstract] [Full Text] [Related]

  • 5. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
    Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D.
    Am J Hum Genet; 1997 May 15; 60(5):1059-67. PubMed ID: 9150153
    [Abstract] [Full Text] [Related]

  • 6. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
    Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Kinoshita M, Noguchi S.
    Int J Cancer; 2001 Jan 01; 91(1):83-8. PubMed ID: 11149425
    [Abstract] [Full Text] [Related]

  • 7. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
    Górski B.
    Hered Cancer Clin Pract; 2006 Aug 15; 4(3):142-52. PubMed ID: 20223018
    [Abstract] [Full Text] [Related]

  • 8. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.
    Santarosa M, Dolcetti R, Magri MD, Crivellari D, Tibiletti MG, Gallo A, Tumolo S, Della Puppa L, Furlan D, Boiocchi M, Viel A.
    Int J Cancer; 1999 Sep 24; 83(1):5-9. PubMed ID: 10449599
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L.
    Cas Lek Cesk; 2000 Oct 11; 139(20):635-7. PubMed ID: 11192759
    [Abstract] [Full Text] [Related]

  • 11. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V.
    Neoplasma; 2006 Oct 11; 53(2):97-102. PubMed ID: 16575464
    [Abstract] [Full Text] [Related]

  • 12. A high proportion of founder BRCA1 mutations in Polish breast cancer families.
    Górski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska Ł, Haus O, Janiszewska H, Niepsuj S, Góźdź S, Zaremba L, Posmyk M, Płuzańska M, Kilar E, Czudowska D, Waśko B, Miturski R, Kowalczyk JR, Urbański K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Tołoczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojć B, Mierzejewski M, Narod SA, Lubiński J.
    Int J Cancer; 2004 Jul 10; 110(5):683-6. PubMed ID: 15146557
    [Abstract] [Full Text] [Related]

  • 13. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
    Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA.
    Am J Hum Genet; 2000 Apr 10; 66(4):1259-72. PubMed ID: 10739756
    [Abstract] [Full Text] [Related]

  • 14. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.
    Håkansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes AM, Holmberg E, Dahl N, Pandis N, Kristoffersson U, Olsson H, Borg A.
    Am J Hum Genet; 1997 May 10; 60(5):1068-78. PubMed ID: 9150154
    [Abstract] [Full Text] [Related]

  • 15. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.
    Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, Lenoir GM, Mazoyer S, Weber BL.
    Am J Hum Genet; 2000 Oct 10; 67(4):841-50. PubMed ID: 10978226
    [Abstract] [Full Text] [Related]

  • 16. Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed.
    Ladopoulou A, Kroupis C, Konstantopoulou I, Ioannidou-Mouzaka L, Schofield AC, Pantazidis A, Armaou S, Tsiagas I, Lianidou E, Efstathiou E, Tsionou C, Panopoulos C, Mihalatos M, Nasioulas G, Skarlos D, Haites NE, Fountzilas G, Pandis N, Yannoukakos D.
    Cancer Lett; 2002 Nov 08; 185(1):61-70. PubMed ID: 12142080
    [Abstract] [Full Text] [Related]

  • 17. Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population.
    Grzybowska E, Siemińska M, Zientek H, Kalinowska E, Michalska J, Utracka-Hutka B, Rogozińska-Szczepka J, Kaźmierczak-Maciejewska M.
    Acta Biochim Pol; 2002 Nov 08; 49(2):351-6. PubMed ID: 12362976
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer.
    Hodgson SV, Heap E, Cameron J, Ellis D, Mathew CG, Eeles RA, Solomon E, Lewis CM.
    J Med Genet; 1999 May 08; 36(5):369-73. PubMed ID: 10353781
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
    Rashid MU, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, Shakoori AR, Seidel-Renkert A, Farooq H, Narod S, Amin A, Hamann U.
    Int J Cancer; 2006 Dec 15; 119(12):2832-9. PubMed ID: 16998791
    [Abstract] [Full Text] [Related]

  • 20. Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?
    Nguyen-Dumont T, Karpinski P, Sasiadek MM, Akopyan H, Steen JA, Theys D, Hammet F, Tsimiklis H, Park DJ, Pope BJ, Slezak R, Stembalska A, Pesz K, Kitsera N, Siekierzynska A, Southey MC, Myszka A.
    Genet Res (Camb); 2020 Aug 10; 102():e6. PubMed ID: 32772980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.